Results 1 to 10 of about 115,229 (243)
Phosphonates and bisphosphonates are stable analogs of phosphates and pyrophosphates that are characterized by one and two carbon–phosphorus bonds, respectively.
Babak Kaboudin +3 more
doaj +2 more sources
PURPOSE To update recommendations of the American Society of Clinical Oncology (ASCO)-Ontario Health (Cancer Care Ontario [CCO]) adjuvant bone-modifying agents in breast cancer guideline.
Mark R Somerfield +2 more
exaly +2 more sources
Bisphosphonates, Old Friends of Bones and New Trends in Clinics
Bisphosphonates, used for a long time in osteoporosis management, are currently the target of intensive research, from pre-formulation studies to more advanced stages of clinical practice.
Jéssica S. Barbosa +2 more
openalex +2 more sources
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Background The standard treatment for osteoporosis was controversial. Denosumab and bisphosphonates were two most common drugs. The purpose of this study was to compare the efficacy and safety of denosumab with bisphosphonates to treat osteoporosis ...
Jiaqi Wu +3 more
doaj +2 more sources
Carpal Tunnel Syndrome Associated with Oral Bisphosphonates. A Population-Based Cohort Study. [PDF]
BackgroundBisphosphonates are widely used to prevent osteoporotic fractures. Some severe musculoskeletal reactions have been described with this medication; among them, some cases of carpal tunnel syndrome.
Alfonso Carvajal +7 more
doaj +2 more sources
Bisphosphonates: Mechanism of Action and Role in Clinical Practice
Sundeep Khosla
exaly +2 more sources
Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors
Aristotelis Bamias +2 more
exaly +2 more sources
Are bisphosphonates effective in the treatment of osteoarthritis pain? A meta-analysis and systematic review. [PDF]
Osteoarthritis (OA) is the most common form of arthritis worldwide. Pain and reduced function are the main symptoms in this prevalent disease. There are currently no treatments for OA that modify disease progression; therefore analgesic drugs and joint ...
AD Beswick +37 more
core +13 more sources
Bisphosphonates have been proposed as possible disease-modifying drugs in osteoarthritis. However, the evidence of their efficacy is poor and their outcomes presented a great heterogeneity. Therefore, the aim of this study is to systematically review the
Silvia Fernández-Martín +4 more
semanticscholar +1 more source
Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
BACKGROUND Bisphosphonates are effective in reducing hip and osteoporotic fractures. However, concerns about atypical femur fractures have contributed to substantially decreased bisphosphonate use, and the incidence of hip fractures may be increasing ...
D. Black +7 more
semanticscholar +1 more source

